Sanjivani Paranteral's Stock Reaches All-Time High, Outperforms Sector and Sensex
Sanjivani Paranteral Ltd, a microcap pharmaceutical company, has reached an all-time high stock price of Rs.360.6 on September 8th, 2024. According to MarketsMojo, the stock call for Sanjivani Paranteral is 'Buy', indicating potential for growth in the pharmaceutical industry. The stock has outperformed the sector today and is currently trading higher than its moving averages, showing a positive trend. With a 1-year performance of 259.36%, Sanjivani Paranteral is a company to watch out for in the microcap pharmaceutical sector.
Sanjivani Paranteral Ltd, a microcap pharmaceutical company, has been making waves in the stock market with its recent performance. On September 8th, 2024, the company's stock price reached an all-time high of Rs.360.6, which is a significant milestone for the company.
According to MarketsMOJO, a leading stock market analysis platform, the stock call for Sanjivani Paranteral is 'Buy'. This is a positive sign for investors who are looking to invest in the pharmaceutical industry.
In terms of price performance, Sanjivani Paranteral has outperformed the sector by 2.15% today. However, the stock has seen a slight dip after five consecutive days of gains, which could be a potential trend reversal. The stock's intraday high was Rs.360.6, showing a 3.92% increase, while the intraday low was Rs.331, a 4.61% decrease.
One notable aspect of Sanjivani Paranteral's stock performance is that it is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock and could be a good sign for investors.
In terms of overall performance, Sanjivani Paranteral has shown an impressive 1-year performance of 259.36%, compared to the Sensex's performance of 23.23%. This further highlights the company's strong performance and potential for growth in the pharmaceutical industry.
With its recent all-time high and positive stock call from MarketsMOJO, Sanjivani Paranteral is definitely a company to watch out for in the microcap pharmaceutical sector. Investors can consider adding this stock to their portfolio for potential long-term growth.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
